GRFS (Grifols) FCF Yield % : -1.61 (As of Oct. 31, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Grifols FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Grifols's Trailing 12-Month Free Cash Flow is $-95 Mil, and Market Cap is $5,906 Mil. Therefore, Grifols's FCF Yield % for today is -1.61%.

The historical rank and industry rank for Grifols's FCF Yield % or its related term are showing as below:

GRFS' s FCF Yield % Range Over the Past 10 Years
Min: -1.62 Med: 2.61 Max: 6.26
Current: -1.61

During the past 13 years, the highest FCF Yield % of Grifols was 6.26%. The lowest was -1.62%. And the median was 2.61%.

GRFS's FCF Yield % is ranked worse than
57.43% of 1036 companies
in the Drug Manufacturers industry
Industry Median: 0 vs GRFS: -1.61

Grifols's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

Grifols FCF Yield % Historical Data

The historical data trend for Grifols's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols FCF Yield % Chart

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

1.09

7.21

4.18

-7.10

-1.21

Grifols Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Grifols's FCF Yield %

For the Drug Manufacturers - General subindustry, Grifols's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Grifols's FCF Yield % falls into.

Grifols FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Grifols's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-95.024	/	7850.30352
	=	-1.21%

Grifols's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	4285.060845
	=	0.00%

Grifols FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Grifols FCF Yield % Related Terms

Thank you for viewing the detailed overview of Grifols's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFOF:USA GIFLF:USA GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0FB:Germany OZTA:Germany OZTA:Germany G0FB:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.